Corgenix Medical Corporation receives approval for third US Patent on AtherOx Technology

Submit press release

Existing customer?
Log in

New customer?
Sign up

Latest Headlines
GE Opens First New Manufacturing Operation in Louisville, Ky...
Get set for Bupa Great Birmingham Run...
New Regional Aircraft Contracts and Support...
Harris Corporation's John Shipley Honored by U.S...
Farmers can use red diesel to help out during extreme weather...
Hogan Lovells' It's Not Just Peanuts Campaign Wins Legal Business...

M2 Archive: Preview

You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.

Corgenix Medical Corporation receives approval for third US Patent on AtherOx Technology
Corgenix Medical Corporation (OTC BB: CONX), a developer and marketer of diagnostic test kits, declared on 25 September the receipt of its third US patent (PATENT # 7,422,864) from the US Patent Office for AtherOx Technology, to identify individuals at risk for developing atherosclerotic...

If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search